1. Home
  2. ALB vs ILMN Comparison

ALB vs ILMN Comparison

Compare ALB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALB

Albemarle Corporation

HOLD

Current Price

$178.01

Market Cap

18.5B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$117.10

Market Cap

19.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALB
ILMN
Founded
1994
1998
Country
United States
United States
Employees
7800
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
19.0B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ALB
ILMN
Price
$178.01
$117.10
Analyst Decision
Buy
Hold
Analyst Count
20
17
Target Price
$171.89
$124.24
AVG Volume (30 Days)
1.8M
1.5M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.93%
N/A
EPS Growth
N/A
170.87
EPS
N/A
5.45
Revenue
N/A
$4,343,000,000.00
Revenue This Year
$10.68
$6.54
Revenue Next Year
$5.82
$5.49
P/E Ratio
N/A
$22.84
Revenue Growth
N/A
N/A
52 Week Low
$49.43
$68.70
52 Week High
$206.00
$155.53

Technical Indicators

Market Signals
Indicator
ALB
ILMN
Relative Strength Index (RSI) 56.53 38.77
Support Level $156.95 $115.02
Resistance Level $182.80 $135.68
Average True Range (ATR) 7.88 4.66
MACD 1.66 0.19
Stochastic Oscillator 80.51 13.18

Price Performance

Historical Comparison
ALB
ILMN

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: